Danshen Dropping Pill for Coronary Heart Disease Heart and Artery Structure and Function

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

Also called NCT01825759

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01825759
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01825759. Allocation not applicable; no masking; primary purpose treatment. Start 2013-01 (registry gives no type); primary completion 2014-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Danshen Dropping Pill for Coronary Heart Disease Heart and Artery Structure and Function
Condition
Coronary Heart Disease
Condition
Essential Hypertension
Intervention (Drug)
danshen dripping pill
Lead sponsor
West China Hospital (class: other)

Record details

Record id
cardio:ct-nct01825759
Content hash
7f455543ef40a0074a6e08593298c55663f10002481be6290f3228619aad7efd